Gene therapy with adeno-associated viral viruses could provide an efficacious, safe, and cost-effective treatment option for patients with hemophilia.
Current transfusion recommendations do not adequately inform transfusion in patients with hematologic malignancies, who are increasingly treated as outpatients.
Current guidelines to diagnosis pulmonary embolism in pregnant patients offer conflicting recommendations.
Transgender women receiving hormone replacement therapy may be at an increased risk for thromboembolism, though data and recommendations vary across studies.
Immune checkpoint inhibitor therapy is associated with improved outcomes but it may also lead to serious adverse effects.